IBEX Ltd IBEX
EDP Services · IPO 2020 · data as of November 13, 2026
IBEX Ltd (IBEX) is a technology company listed in the US with a market value of about $759M. In the twelve months to September 30, 2026 it had revenue of $668M and net income of $49M, a net margin of 7.3%.
Its overall Stock Analiz score is 3.4 out of 5 (good). The strongest part is financial health (5/5); the weakest is shareholder returns (2/5).
Key numbers: a P/E of 17.2, a price to free cash flow of 23.5, 5-year revenue growth of 8% a year, a 5-year average ROIC of 15%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 29% below the current price.
About IBEX
IBEX is listed in the US and classified in edp services, IPO year 2020. Revenue went from $342M in 2018 to $644M in 2026, growth of about 8.2% a year. It was profitable in 8 of the last 9 years in our data.
Score: 3.4 / 5
Checks passed
- P/E below 25
- P/E below the industry median
- PEG below 1.5
- Revenue growth above 10% last year
- Profit margin improving
- 3-year free cash flow growth above 10% a year
- 5-year EPS growth above 10% a year
- 5-year average ROIC above 12%
Checks not passed
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- 3-year revenue growth above 10% a year
- Strong R&D investment or growth above 20%
- 5-year revenue growth above 8% a year
- Pays a dividend
- Share count down over 3 years (buybacks)
- Dividend 3 years in a row
Valuation
Growth and quality
Financials, last 9 years
| Fiscal year | TTM | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $668M | $644M | $558M | $509M | $523M | $493M | $443M | $405M | $368M | $342M |
| Net income | $49M | $46M | $37M | $34M | $32M | $21M | $13M | $8M | $11M | -$16M |
| Free cash flow | $32M | $31M | $27M | $27M | $23M | $14M | -$5M | $47M | -$3M | -$11M |
| EPS (diluted) | $3.30 | $3.47 | $2.76 | $2.52 | $2.37 | $1.61 | $0.98 | $0.58 | $0.82 | $-1.19 |
| Net margin | 7.3% | 7.2% | 6.6% | 6.6% | 6.0% | 4.3% | 2.9% | 1.9% | 3.0% | -4.6% |
| ROIC | — | 20.2% | 18.3% | 13.9% | 13.9% | 7.4% | 11.9% | 30.1% | 9.6% | -68.2% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
What analysts expect
The average 12-month price target from 2 analysts is $46.50, 18% below the current price; targets range from $45.00 to $48.00; the consensus rating is “Hold”; expected EPS is $4.08 for the fiscal year ending June 30, 2027.
Frequently asked questions
What is IBEX’s P/E ratio?
About 17.2, based on the last twelve months of diluted earnings per share (forward P/E about 13.6).
Is IBEX stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 29% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does IBEX pay a dividend?
Not currently.
Is IBEX a good stock to buy?
We do not give buy or sell advice. IBEX scores 3.4 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.